Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system.
暂无分享,去创建一个
Ting Wang | Ning Wang | Yihui Deng | Yihui Deng | Meiling Zhang | Ruonan Chen | Ruowen Niu | Ruowen Niu | Ting Wang | Ning Wang | Ruonan Chen | Meiling Zhang
[1] Division on Earth. Guide for the Care and Use of Laboratory Animals , 1996 .
[2] M. Schmidt,et al. A stable and highly sensitive 3,3',5,5'-tetramethylbenzidine-based substrate reagent for enzyme-linked immunosorbent assays. , 2000, Journal of immunological methods.
[3] Kyung‐Yeol Lee,et al. Mucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination , 2012, Immune network.
[4] M. Bevan. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay , 1976, The Journal of experimental medicine.
[5] Xin Jin,et al. A novel procedure for preparation of submicron liposomes-lyophilization of oil-in-water emulsions , 2009, Journal of liposome research.
[6] Shawn T. Brown,et al. The impact of making vaccines thermostable in Niger's vaccine supply chain. , 2012, Vaccine.
[7] K. Rock,et al. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[8] A. Takahara,et al. Bovine serum albumin adsorption onto immobilized organotrichlorosilane surface: influence of the phase separation on protein adsorption patterns. , 1998, Journal of biomaterials science. Polymer edition.
[9] M. Kweon. Sublingual mucosa: A new vaccination route for systemic and mucosal immunity. , 2011, Cytokine.
[10] W. Hinrichs,et al. Devices and formulations for pulmonary vaccination , 2013, Expert opinion on drug delivery.
[11] Anthony J Hickey,et al. Stable dry powder formulation for nasal delivery of anthrax vaccine. , 2012, Journal of pharmaceutical sciences.
[12] Douglas G Altman,et al. Guidelines for the design and statistical analysis of experiments using laboratory animals. , 2002, ILAR journal.
[13] P. Cresswell,et al. Enhanced and prolonged cross‐presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles , 2006, Immunology.
[14] C. H. Fiske,et al. THE COLORIMETRIC DETERMINATION OF PHOSPHORUS , 1925 .
[15] Thomas C. Mitchell,et al. The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4 , 2007, Science.
[16] Dexiang Chen,et al. Desirable attributes of vaccines for deployment in low-resource settings. , 2013, Journal of pharmaceutical sciences.
[17] V. Ferro,et al. Optimizing efficacy of mucosal vaccines , 2012, Expert review of vaccines.
[18] N. Lycke. Recent progress in mucosal vaccine development: potential and limitations , 2012, Nature Reviews Immunology.
[19] S. Ozawa,et al. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review. , 2012, Vaccine.
[20] G. Barratt,et al. Interactions of antileishmanial drugs with monolayers of lipids used in the development of amphotericin B-miltefosine-loaded nanocochleates. , 2013, Colloids and surfaces. B, Biointerfaces.
[21] Yuqin Qiu,et al. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant. , 2013, International journal of pharmaceutics.
[22] Alan S. Perelson,et al. Th1/Th2 differentiation and cross-regulation , 1999, Bulletin of mathematical biology.
[23] H. Kiyono,et al. Mucosal vaccines: novel advances in technology and delivery , 2009, Expert review of vaccines.
[24] J. Rhee,et al. Mannose-poly(ethylene glycol)-linked SPION targeted to antigen presenting cells for magnetic resonance imaging on lymph node. , 2013, Carbohydrate polymers.
[25] H. Kiyono,et al. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination , 2007, Proceedings of the National Academy of Sciences.
[26] C. Elson,et al. Perspectives on Mucosal Vaccines: Is Mucosal Tolerance a Barrier?1 , 2007, The Journal of Immunology.
[27] M. Levine. "IDEAL" vaccines for resource poor settings. , 2011, Vaccine.
[28] L. Zarif. Drug delivery by lipid cochleates. , 2005, Methods in enzymology.
[29] G. Matyas,et al. Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines , 2012, Expert review of vaccines.
[30] J. C. Domingo,et al. Preparation of long-circulating immunoliposomes using PEG-cholesterol conjugates: effect of the spacer arm between PEG and cholesterol on liposomal characteristics. , 2001, Chemistry and physics of lipids.
[31] R. Coppel,et al. Oral vaccine delivery: can it protect against non-mucosal pathogens? , 2008, Expert review of vaccines.
[32] I. Toth,et al. Modern Subunit Vaccines: Development, Components, and Research Opportunities , 2013, ChemMedChem.
[33] N. Mishra,et al. Surface modified liposomes for nasal delivery of DNA vaccine. , 2008, Vaccine.
[34] Wei Sun,et al. Preparation of submicron liposomes exhibiting efficient entrapment of drugs by freeze-drying water-in-oil emulsions. , 2011, Chemistry and physics of lipids.
[35] Jun Chang,et al. Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection , 2013, PloS one.
[36] C. H. Fiske,et al. THE COLORIMETRIC DETERMINATION OF PHOSPHOROUS , 1925 .
[37] T. Mitchell,et al. Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant , 2008, Cellular and Molecular Life Sciences.
[38] M. Lastre,et al. Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses. , 2009, Methods.
[39] Hidde L. Ploegh,et al. The known unknowns of antigen processing and presentation , 2008, Nature Reviews Immunology.
[40] A. Talavera,et al. An approach to a cold chain free oral cholera vaccine: in vitro and in vivo characterization of Vibrio cholerae gastro-resistant microparticles. , 2013, International journal of pharmaceutics.
[41] Istvan Toth,et al. Strategies for intranasal delivery of vaccines , 2012, Drug Delivery and Translational Research.
[42] V. Schijns,et al. Trends in vaccine adjuvants , 2011, Expert review of vaccines.
[43] S. Plotkin,et al. Vaccines: past, present and future , 2005, Nature Medicine.
[44] F. M. Sutera,et al. Physical methods to promote drug delivery on mucosal tissues of the oral cavity , 2013, Expert opinion on drug delivery.
[45] Jianan Wang,et al. Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[46] A. Crean,et al. Microneedle Array Design Determines the Induction of Protective Memory CD8+ T Cell Responses Induced by a Recombinant Live Malaria Vaccine in Mice , 2011, PloS one.
[47] Ying-jie Deng,et al. Preparation of submicron unilamellar liposomes by freeze-drying double emulsions. , 2006, Biochimica et biophysica acta.
[48] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[49] C. Cutler,et al. Dendritic Cells at the Oral Mucosal Interface , 2006, Journal of dental research.
[50] J. Irache,et al. Mannose-targeted systems for the delivery of therapeutics , 2008, Expert opinion on drug delivery.
[51] O. Pérez,et al. Delivery systems: a vaccine strategy for overcoming mucosal tolerance? , 2009, Expert review of vaccines.
[52] Sidney Udenfriend,et al. Fluorescamine: A Reagent for Assay of Amino Acids, Peptides, Proteins, and Primary Amines in the Picomole Range , 1972, Science.
[53] C. Czerkinsky,et al. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. , 2003, Vaccine.